Journal
TUMOR BIOLOGY
Volume 39, Issue 6, Pages 1-11Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1010428317705338
Keywords
Hepatocellular carcinoma; plasmacytoma variant translocation I; miR-I86-5p; yes-associated protein I; competing endogenous RNA; endogenous sponge
Categories
Funding
- Science and Technology Project of Wuhan [2013060501010153]
- Health and Family Planning Commission of Hubei Province [WJ2017Z007]
Ask authors/readers for more resources
Hepatocellular carcinoma is third leading cause of cancer-related death globally. Long non-coding RNA plasmacytoma variant translocation I has been reported to be dysregulated and plays a crucial role in various cancers. In this study, we investigated the interactions between plasmacytoma variant translocation I and miR-I86-5p in the progression of hepatocellular carcinoma and explored the functional significance of plasmacytoma variant translocation I. It was determined that plasmacytoma variant translocation I was significantly higher, while miR-I86-5p was statistically lower in the hepatocellular carcinoma tissues than that in the adjacent normal tissues. Using gain-of-function and loss-of-function methods, our results revealed that plasmacytoma variant translocation I affected hepatocellular carcinoma cells proliferation, invasion, and migration. It was found that there was direct interaction between miR-I86-5p and the binding site of plasmacytoma variant translocation I by performing dual-luciferase assay and RNA immunoprecipitation assay. Furthermore, it was identified that plasmacytoma variant translocation I regulated the expression of the miR-I86-5p target gene, yes-associated protein I. Taken together, plasmacytoma variant translocation I served as an endogenous sponge for miR-I86-5p to reduce its inhibiting effect on yes-associated protein I and thus promoted the tumorigenesis of hepatocellular carcinoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available